Metformin therapy and circulating NT-proBNP levels: the CAMERA trial

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial

Bibliografski detalji
Glavni autori:	Preiss, D, Welsh, P, Sattar, N
Format:	Journal article
Izdano:	American Diabetes Association 2016

Slični predmeti

The integration of BNP and NT-proBNP into clinical medicine
od: Swiss Medical Weekly
Izdano: (2007-01-01)

Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
od: Benedikt Seither, i dr.
Izdano: (2024-11-01)

In-hospital mortality is associated with high NT-proBNP level.
od: Malik Benmachiche, i dr.
Izdano: (2018-01-01)

Sendaway capillary NT-proBNP in pulmonary hypertension
od: Eleanor Morris, i dr.
Izdano: (2024-07-01)

The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
od: Angeliki Mouzarou, i dr.
Izdano: (2025-01-01)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
od: A Palazzuoli, i dr.
Izdano: (2010-05-01)

Highly sensitive detection of NT-proBNP by molecular motor
od: Jie Zhang, i dr.
Izdano: (2017-03-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
od: Aidonis Rammos, i dr.
Izdano: (2023-08-01)

Serum NT-ProBNP potential marker of cirrhotic cardiomyopathy
od: Maya Risteska, i dr.
Izdano: (2022-10-01)

NT-proBNP and prognostics variables in acute myocardial infarction
od: Jorge Vendrell Cabrera, i dr.
Izdano: (2012-01-01)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
od: Yuancheng Zhao, i dr.
Izdano: (2023-12-01)

Association between NT-proBNP Level and the Severity of COVID-19 Pneumonia
od: Lan Wang, i dr.
Izdano: (2021-01-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
od: H.M. Kim, i dr.
Izdano: (2020-08-01)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
od: Robert A. Lewis, i dr.
Izdano: (2020-05-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
od: O.O. Samchuk, i dr.
Izdano: (2023-06-01)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
od: Reinhard Henrik, i dr.
Izdano: (2011-08-01)

The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
od: Gina Sado, i dr.
Izdano: (2024-12-01)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
od: Huiqi Jiang, i dr.
Izdano: (2019-05-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
od: Yu. V. Dubolazova, i dr.
Izdano: (2017-02-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
od: Chin-Shern Lau, i dr.
Izdano: (2022-05-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
od: Maria António, i dr.
Izdano: (2023-07-01)

Using NT-proBNP as a criterion for heart failure hospitalization
od: Babak Tamizifar, i dr.
Izdano: (2012-01-01)

NT-proBNP na estratificação de risco no tromboembolismo pulmonar
od: Hélder Dores, i dr.
Izdano: (2011-12-01)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
od: Lucian MURESAN, i dr.
Izdano: (2017-06-01)

NT-proBNP in Myocarditis after a Scorpion Sting Envenomation
od: Suresh V Sagarad, i dr.
Izdano: (2013-01-01)

NT-proBNP and Echocardiographic Parameters in Patients with Acute Heart Failure
od: Radek Pudil, i dr.
Izdano: (2007-01-01)

The effect of metformin treatment on the level of GLP-1, NT-proBNP and endothelin-1 in patients with type 2 diabetes mellitus
od: L.K. Sokolova, i dr.
Izdano: (2020-11-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
od: Hussein Alawieh, i dr.
Izdano: (2019-11-01)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV
od: Mads-Holger Bang Jacobsen, i dr.
Izdano: (2023-01-01)

Pretransplant NT‐proBNP levels are associated with mortality among lung transplant recipients
od: Shimon Izhakian, i dr.
Izdano: (2024-07-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
od: V. I. Podzolkov, i dr.
Izdano: (2023-01-01)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
od: Bader Alsuwailem, i dr.
Izdano: (2021-01-01)

A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients
od: Cesar Navarro, i dr.
Izdano: (2020-01-01)

Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure
od: Kanako Teramoto, i dr.
Izdano: (2024-05-01)

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients
od: Jacques Ducros, i dr.
Izdano: (2017-01-01)

Prognostic value of NT-proBNP in the new era of heart failure treatment.
od: Dat Vu Nguyen, i dr.
Izdano: (2024-01-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
od: I. A. Kozlov, i dr.
Izdano: (2023-02-01)

Analytical and clinical performance evaluation of a new NT-proBNP assay
od: Pingfeng Feng, i dr.
Izdano: (2024-07-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
od: Irina Cuciureanu, i dr.
Izdano: (2021-03-01)

NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
od: Paweł Komarnicki, i dr.
Izdano: (2023-09-01)